Skip to main content

Find Clinical Trials

Home
Conditions
Hay Fever

Clinical trial condition

Hay Fever

Explore clinical trials studying Hay Fever. Study availability and eligibility vary by location and protocol.

27 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Hay Fever trial results

Completed

Safety and Tolerability of Ciclesonide Nasal Spray in Patients With Perennial Allergic Rhinitis (2-5 Years Old) (BY9010/M1-416)

NCT00261287

Conditions: Hay Fever, Hypersensitivity, Hypersensitivity, Immediate, +10 more
Locations: Altana Pharma/Nycomed Long Beach, California, United States

Altana Pharma/Nycomed Normal, Illinois, United States

Altana Pharma/Nycomed San Antonio, Texas, United States

View Trial Details

Completed

Omalizumab (Xolair) and Allergy Shots For the Treatment of Seasonal Allergies

NCT00078195

Conditions: Allergy, Hay Fever, Hypersensitivity, +11 more
Locations: University of Iowa Iowa City, Iowa, United States

Creighton University Omaha, Nebraska, United States

University of Wisconsin Madison, Wisconsin, United States

View Trial Details

Completed

Evaluation of High Speed Laser Doppler Imaging Technology

NCT02619331

Conditions: Hay Fever, Hypersensitivity, Hypersensitivity, Immediate, +8 more
Locations: CHUV , Division of Immunology and Allergy Lausanne, Switzerland

View Trial Details

Completed

Safety, Clinical Tolerability and Immunogenicity of Increasing Doses of gpASIT+TM

NCT02156791

Conditions: Hay Fever, Hypersensitivity, Hypersensitivity, Immediate, +8 more
Locations: Universitätsklinikum Carl-Gustav-Carus, Dresden, Germany Dresden, Germany

View Trial Details

Completed

Safety of gpASIT+TM Subcutaneously Administered to Hay Fever Patients With or Without Immunoregulating Adjuvant

NCT01506375

Conditions: Hay Fever, Hypersensitivity, Hypersensitivity, Immediate, +8 more
Locations: Universitaire Ziekenhuis van Leuven Leuven, Belgium

View Trial Details

Completed

Clinical Efficacy and Safety of gpASIT+TM to Treat Seasonal Allergic Rhinoconjunctivitis

NCT01308021

Conditions: Grass Pollen Allergy, Hay Fever, Hypersensitivity, +9 more
Locations: CHR Saint Joseph Warquignies Boussu, Belgium

AZ Sint Lucas Bruges, Belgium

Clinique du Parc Léopold Brussels, Belgium

UZ Brussel Brussels, Belgium

View all 19 locations

View Trial Details

Completed

Probiotics for Reduction Of Markers In Subjects With Allergy

NCT01137357

Conditions: Birch Pollen Allergy, Hay Fever, Hypersensitivity, +9 more
Locations: Allergologiepraktijk Arnhem/Radboud/Rijnstate Arnhem, Gelderland, Netherlands

View Trial Details